Communiqués de presse | Articles récents

February 26, 2024

Clinical Research on Photon-Counting CT Begins with Radboud University Medical Center

Canon Medical Systems Corporation has completed the second installation of its Canon photon-counting CT system worldwide at Radboud University Medical Center, and clinical research began in late January. PCCT is expected to be the next generation of X-ray CT.

November 17, 2023

Canon Medical Systems Accelerates Global Clinical Research to Realize Next-Generation Photon-Counting CT

Canon Medical Systems is accelerating clinical research both domestically and internationally to promote the practical application of Photon Counting CT (PCCT). PCCT holds great promise as a next-generation diagnostic imaging method.

September 15, 2023

Unlocking Synergies: Hospital Management Meets Elite Sports Teams in Virtual Round Table

Otawara, Tochigi Prefecture, Japan, 12 September 2023 — Canon Medical is proud to announce an insightful round table discussion on effective leadership and team management. Titled "Management in Motion: Exploring Synergies Between Hospital Management and Elite Level Sports Teams," this dynamic event is scheduled for October 3rd 8:00 pm CEST, offering invaluable insights for C-suite executives, decision-makers, and healthcare professionals.

April 12, 2023

Start of Clinical Research of the First Japanese Produced Next-Generation Photon-Counting Computed Tomography

Canon Inc., Canon Medical Systems Corporation, and the National Cancer Center Japan have begun clinical research employing a next-generation X-ray CT system with photon counting computed tomography.

November 28, 2022

Canon Medical Unveils Paradigm Shift in Productivity of MR Portfolio

Canon Medical today unveiled a major revamp to their MR Vantage portfolio at RSNA 2022 - with advanced productivity and AI solutions for automation and image enhancement. The new systems feature a refined new look along with innovative workflow solutions, image enhancement and accelerated scan technology, which together, can contribute to reducing the total time required for MRI procedures.

November 7, 2022

First Domestically Produced X-ray CT System with Photon-counting Detector Installed at National Cancer Center Japan Exploratory Oncology Research ＆ Clinical Trial Center

TOKYO, November 7, 2022—Last year, Canon Inc. acquired Redlen Technologies Inc., one of the world's leading companies in creating new technologies related to the development and manufacture of semiconductor detector modules. Canon Medical Systems Corporation, a group company of Canon Inc., has developed the first domestically produced photon-counting CT system incorporating Redlen's advanced technologies. This system has been installed at the National Cancer Center Exploratory Oncology Research ＆ Clinical Trial Center in Japan, where it is currently used to conduct research exploring the clinical applications of PCCT.

March 1, 2022

Canon Medical Systems acquires Danish medical equipment manufacturer Nordisk Røntgen Teknik A/S to strengthen its global X-ray business

Canon Medical Systems Corporation today announces that it has entered into an agreement to acquire Nordisk Røntgen Teknik A/S, a Danish company, headquartered in Aarhus, with advanced technology for the development and manufacture of diagnostic X-ray systems, with the acquisition being completed following the necessary approval procedures.

November 30, 2021

Canon Medical and Resoundant, Inc. Partnership to Provide Magnetic Resonance Elastography on Canon MRI Scanners

Otawara, Tochigi Prefecture, Japan, November 30, 2021 – Canon Medical Systems Corporation and Resoundant, Inc. (Rochester, MN, USA) have signed a licensing agreement for the purpose of incorporating the advanced Magnetic Resonance Elastography (MRE), developed by Resoundant on the Canon MRI platforms. Canon Medical and Resoundant have been working closely together to implement a seamless integration of the latest MRE technology on Canon’s newest line of MRI scanners.

November 26, 2021

Canon Medical signals its support for a multicenter ultrasound liver evaluation and assessment study.

Otawara, Tochigi Prefecture, Japan, 26 November 2021 - Canon Medical announced today its support for the iLEAD (innovative Liver, Elasticity, Attenuation and Dispersion) study, an international multicenter study aiming to evaluate quantitative ultrasound imaging tools against liver biopsy (the current clinical gold standard), available on the Aplio Liver Package for the assessment of Steatosis, Fibrosis, and Inflammation in the clinical environment.

November 25, 2021

Canon Medical Introduces Super-Resolution Deep-Learning Reconstruction for Cardiac CT Scans

Otawara, Tochigi Prefecture, Japan, 25 November 2021 – Canon Medical is breaking ground once again with the introduction of Precise IQ Engine (PIQE) DLR and SilverBeam filter in the latest version of the Aquilion ONE / PRISM edition.

November 24, 2021

Canon Medical reinforces commitment to AI innovation with new Altivity brand

Otawara, Tochigi Prefecture, Japan, 24 November 2021 -- Canon Medical has today announced the launch of Altivity, a new AI innovation brand, that consolidates machine learning and deep learning technologies to deliver uncompromised quality and value across the entire care pathway.

November 23, 2021

Canon Medical’s All-New 12”×16” High-Definition (Hi-Def) Imaging Detector Provides Highest Resolution in the Market to Help Clinicians See Fine Details

Available on the Alphenix Sky +, 4D CT with Sky +, Biplane, and Core+ systems. The 12”×16” Hi-Def flat panel detector offers the highest resolution on interventional X-ray systems in the market.

October 7, 2021

Canon Medical Deepens Commitment to ‘Made for Life’ with Virtual Exhibition and Educational Experience

Otawara, Tochigi Prefecture, Japan, 7 October 2021 -- Canon Medical announced today that due to recent developments in the Covid-19 pandemic, it will be attending all further relevant, major US-based global conferences in 2021, with a digital presence only. This includes the Radiological Society of North America (RSNA) 2021 and ASTRO 2021. The company aims to deliver the best experience virtually rather than present physically and is enhancing their comprehensive virtual exhibition and educational platform to deliver a stand-out experience.

August 31, 2021

Commencement of Research Collaboration into Japan's first Photon Counting Computed Tomography with National Cancer Center Japan

Canon Medical Systems Corporation has begun a collaborative research project with the National Cancer Center Japan Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC) and EAST Hospital to investigate the clinical usefulness of photon counting computed tomography (PCCT), a next-generation diagnostic imaging system. This collaborative research is based on a framework agreement formalized in July 2020 and a basic joint research agreement in November with the National Cancer Center Japan.

July 20, 2021

Canon Medical announces strategic changes to reinforce global HIT division

Canon Medical Systems Corporation has today announced a major operational plan to strengthen its healthcare information technology (HIT) division.

July 27, 2020

Canon Medical and FC Barcelona renew five-season partnership deal

Canon Medical and FC Barcelona have today announced a renewal of their partnership deal, which will see the medical device company supplying the club with leading-edge diagnostic imaging systems for a further five seasons.

July 27, 2020

Canon Medical to partner with Real Madrid until 2025

Canon Medical and Real Madrid have today announced that the Japanese medical device company will remain the club’s official diagnostic imaging partner for a further five seasons.

March 26, 2020

Rapid Genetic Testing System for the Novel Coronavirus (SARS-CoV-2) Jointly Developed by Canon Medical Systems Corporation and Nagasaki University Now Available for Practical Application in Government-Conducted Testing

Canon Medical Systems Corporation, working together with Nagasaki University, has completed development of Genelyzer KIT, a set of reagents for SARS-CoV-2 RNA testing based on a gene amplification technique known as the fluorescent LAMP method.

March 19, 2020

Development of a Rapid Genetic Testing System for the Novel Coronavirus and Start of Research into Its Practical Application

Canon Medical Systems Corporation has begun research into the practical application of a new rapid genetic testing system for the novel coronavirus (SARS-CoV-2) which is being developed by Canon Medical Systems Corporation in cooperation with Nagasaki University.

February 25, 2020

Canon Medical to commence development of a rapid genetic testing system for the Novel Coronavirus (COVID-19)

Ohtawara, Japan; February 26 Canon Medical Systems Corporation (Canon Medical) announces the start of development of a rapid genetic testing system for the novel coronavirus (COVID-19) reaffirming the company’s commitment to the basic research and development of rapid diagnostic test kits.

Older

Communiqués de presse

Nous contacter